Counterfeit/copy drugs: patients safety in the heart
Some studies demonstrate that a large proportion of copy drugs contain lower levels of active substances and higher impurity levels than reference drugs. The number of copy drugs failing to meet internationally recognised quality criteria consequences of patients receiving lower doses of active substances than expected. In addition, possible clinical effect of impurities must be considered. Counterfeiting of drugs exhibits a significant and growing threat to human health and public safety.
一些研究表明，大部分的仿制药品含有比参考药品更低级别的活性物质和更高级别的杂质。 能满足国际公认质量标准的仿制药品导致患者接受比预期更少剂量的活性物质。 此外，必须考虑杂质可能导致的临床效应。 假冒药品对人类健康和公共安全造成重大威胁，并且此威胁正在增加。
- Abstract views: 472
- PDF: 474
Copyright (c) 2011 Y. Capan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.